S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Bed Bath & Beyond Is Circling the Drain
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Bed Bath & Beyond Is Circling the Drain
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Bed Bath & Beyond Is Circling the Drain
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Bed Bath & Beyond Is Circling the Drain
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
OTCMKTS:CVALF

Covalon Technologies - CVALF Stock Forecast, Price & News

$1.60
0.00 (0.00%)
(As of 02/1/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.60
▼
$1.60
50-Day Range
$1.57
▼
$1.81
52-Week Range
$1.26
▼
$2.14
Volume
N/A
Average Volume
1,601 shs
Market Capitalization
$40.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CVALF stock logo

About Covalon Technologies (OTCMKTS:CVALF) Stock

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. It focuses on the wound care, infection management, and surgical procedures. The firm sells its products under the brand name Covalon. Its products categories include advanced wound care, vascular access, perioperative care, and urology. The company was founded on April 28, 2004 and is headquartered in Mississauga, Canada.

Receive CVALF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter.

CVALF Stock News Headlines

January 26, 2023 | msn.com
Covalon Technologies GAAP EPS of -$0.16, revenue of $5.39M
November 29, 2022 | finance.yahoo.com
Covalon to Present at the Planet MicroCap Investor Showcase: VIRTUAL 2022 on Wednesday, December 7, 2022
February 2, 2023 | Investor Place Media (Ad)
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
November 21, 2022 | finance.yahoo.com
Covalon's SurgiClear Dressing Plays an Important Part in Preventing Surgical Wound Infections at Top Children's Hospital
November 1, 2022 | finance.yahoo.com
Closing Chronic Wounds with Collagen Powder: University of Michigan case study demonstrates the efficacy of ColActive Plus Powder in resolving non-healing wounds
September 28, 2022 | finance.yahoo.com
Covalon to Participate in the 12th International Pediatric Intestinal Failure and Rehabilitation Symposium in Toronto
September 13, 2022 | finance.yahoo.com
Covalon to Introduce New Infection Prevention Products at the Annual Association of Pediatric Hematology/Oncology Nurses (APHON) Conference
August 24, 2022 | finance.yahoo.com
Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2022 Financial Results
February 2, 2023 | Investor Place Media (Ad)
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
June 2, 2022 | finance.yahoo.com
A Covalon Technologies Ltd. (CVE:COV) insider increased their holdings by 5.7% last year
April 28, 2022 | finance.yahoo.com
Covalon Technologies Ltd. to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022
March 2, 2022 | seekingalpha.com
Covalon Technologies Ltd. 2021 Q4 - Results - Earnings Call Presentation
February 16, 2022 | finance.yahoo.com
Covalon Announces Conference Call to Discuss First Quarter Fiscal 2022 Financial Results
December 24, 2021 | nasdaq.com
Covalon CFO Danny Brannagan To Step Down In January 2022
December 24, 2021 | finance.yahoo.com
Covalon Announces CFO Transition
December 13, 2021 | finance.yahoo.com
Covalon Announces Strong Year End and Fourth Quarter Results for Fiscal 2021
December 8, 2021 | finance.yahoo.com
Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2021 Financial Results
December 3, 2021 | finance.yahoo.com
Covalon Technologies to Present at the SNN Network Canada Virtual Event on Wednesday, December 8, 2021
October 29, 2021 | finance.yahoo.com
Investors in Covalon Technologies (CVE:COV) have made a impressive return of 145% over the past year
September 24, 2021 | finance.yahoo.com
Covalon Announces Retirement of Board Member
August 26, 2021 | finance.yahoo.com
Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2021 Financial Results
June 17, 2021 | finance.yahoo.com
Estimating The Intrinsic Value Of Covalon Technologies Ltd. (CVE:COV)
May 29, 2021 | ca.finance.yahoo.com
UPDATE 1-Boeing to pay $17 mln in FAA settlement over 737 MAX, NG equipment
May 27, 2021 | finance.yahoo.com
Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2021 Financial Results
January 6, 2021 | finance.yahoo.com
Aging well in Quebec: A portrait of the inequalities between generations and between seniors
January 6, 2021 | finance.yahoo.com
Winshear Gold Secures Funding for Legal Proceedings Against the Government of Tanzania
See More Headlines
Receive CVALF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter.

CVALF Company Calendar

Today
2/02/2023
Next Earnings (Estimated)
2/27/2023
Fiscal Year End
9/30/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Health services
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CVALF
CUSIP
N/A
CIK
N/A
Web
www.covalon.com
Phone
(905) 568-8400
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.29)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-7,410,000.00
Net Margins
-53.06%
Pretax Margin
N/A
Return on Equity
-30.01%
Return on Assets
-25.25%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$13.91 million
Price / Sales
2.89
Cash Flow
$0.03 per share
Price / Cash Flow
46.66
Book Value
$1.02 per share
Price / Book
1.57

Miscellaneous

Outstanding Shares
25,126,000
Free Float
N/A
Market Cap
$40.20 million
Optionable
Not Optionable
Beta
-0.49

Key Executives

  • Brian E. Pedlar
    President, Chief Executive Officer & Director
  • Elaine Zhang
    Vice President-Operations
  • Jason F. Gorel
    Chief Financial Officer
  • Valerio DiTizio
    Chief Scientific Officer
  • Hector Padilla
    Vice President-Strategic Markets

Key Competitors

View All Competitors













CVALF Stock - Frequently Asked Questions

How have CVALF shares performed in 2023?

Covalon Technologies' stock was trading at $1.6490 at the beginning of 2023. Since then, CVALF stock has decreased by 3.0% and is now trading at $1.60.
View the best growth stocks for 2023 here.

Are investors shorting Covalon Technologies?

Covalon Technologies saw a increase in short interest in January. As of January 15th, there was short interest totaling 600 shares, an increase of 500.0% from the December 31st total of 100 shares. Based on an average daily trading volume, of 600 shares, the days-to-cover ratio is currently 1.0 days.
View Covalon Technologies' Short Interest.

When is Covalon Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 27th 2023.
View our CVALF earnings forecast.

What is Covalon Technologies' stock symbol?

Covalon Technologies trades on the OTCMKTS under the ticker symbol "CVALF."

How do I buy shares of Covalon Technologies?

Shares of CVALF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Covalon Technologies' stock price today?

One share of CVALF stock can currently be purchased for approximately $1.60.

How much money does Covalon Technologies make?

Covalon Technologies (OTCMKTS:CVALF) has a market capitalization of $40.20 million and generates $13.91 million in revenue each year. The company earns $-7,410,000.00 in net income (profit) each year or ($0.29) on an earnings per share basis.

How can I contact Covalon Technologies?

Covalon Technologies' mailing address is 1660 Tech Avenue Unit 5, Mississauga A6, L4W 5S7. The official website for the company is www.covalon.com. The company can be reached via phone at (905) 568-8400 or via email at bpedlar@covalon.com.

This page (OTCMKTS:CVALF) was last updated on 2/2/2023 by MarketBeat.com Staff